|
SAGE
|
Sage Therapeutics, Inc.
|
1.45%
|
US
|
NASDAQ
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
1.44%
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
1.34%
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
1.33%
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
1.29%
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
1.27%
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
1.25%
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
1.23%
|
US
|
NASDAQ
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
1.16%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
1.12%
|
US
|
NASDAQ
|
|
VRNA
|
Verona Pharma plc
|
1.11%
|
US
|
NASDAQ
|
|
VTYX
|
Ventyx Biosciences, Inc.
|
1.10%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
1.09%
|
US
|
NASDAQ
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
1.04%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.98%
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.98%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.97%
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
0.95%
|
US
|
NASDAQ
|
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.92%
|
US
|
NASDAQ
|
|
ACLX
|
Arcellx, Inc.
|
0.89%
|
US
|
NASDAQ
|